Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial.

de Bruijn AM, Ankum WM, Reekers JA, Birnie E, van der Kooij SM, Volkers NA, Hehenkamp WJ.

Am J Obstet Gynecol. 2016 Dec;215(6):745.e1-745.e12. doi: 10.1016/j.ajog.2016.06.051. Epub 2016 Jul 5.

PMID:
27393268
2.

Susac syndrome: a report of four cases and a review of the literature.

van der Kooij SM, van Buchem MA, Overbeek OM, Dijkman G, Huizinga TW.

Neth J Med. 2015 Jan;73(1):10-6. Review.

3.

Epidural analgesia versus patient-controlled analgesia for pain relief in uterine artery embolization for uterine fibroids: a decision analysis.

van der Kooij SM, Moolenaar LM, Ankum WM, Reekers JA, Mol BWJ, Hehenkamp WJK.

Cardiovasc Intervent Radiol. 2013 Dec;36(6):1514-1520. doi: 10.1007/s00270-013-0607-1. Epub 2013 Apr 11.

PMID:
23576212
4.

The effect of treatment preference and treatment allocation on patients' health-related quality of life in the randomized EMMY trial.

van der Kooij SM, Hehenkamp WJ, Birnie E, Ankum WM, Mol BW, Scherjon S, Reekers JA.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(1):69-74. doi: 10.1016/j.ejogrb.2013.01.019. Epub 2013 Mar 6.

PMID:
23474384
5.

Review of nonsurgical/minimally invasive treatments for uterine fibroids.

van der Kooij SM, Ankum WM, Hehenkamp WJ.

Curr Opin Obstet Gynecol. 2012 Dec;24(6):368-75. doi: 10.1097/GCO.0b013e328359f10a. Review.

PMID:
23014141
6.

Implementation of uterine artery embolisation for symptomatic uterine fibroids: an inventory.

van der Kooij SM, Klint E, Hehenkamp WJ, Bipat S, Ankum WM, Reekers JA.

Neth J Med. 2011 Jun;69(6):274-8.

7.

Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis.

van der Kooij SM, Bipat S, Hehenkamp WJ, Ankum WM, Reekers JA.

Am J Obstet Gynecol. 2011 Oct;205(4):317.e1-18. doi: 10.1016/j.ajog.2011.03.016. Epub 2011 Mar 16. Review.

PMID:
21641570
8.

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.

Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, Seys PE, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.

PMID:
21415052
9.

Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study.

Klarenbeek NB, van der Kooij SM, Güler-Yüksel M, van Groenendael JH, Han KH, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Feb;70(2):315-9. doi: 10.1136/ard.2010.136556. Epub 2010 Nov 10.

PMID:
21068104
10.

Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial.

van der Kooij SM, Hehenkamp WJ, Volkers NA, Birnie E, Ankum WM, Reekers JA.

Am J Obstet Gynecol. 2010 Aug;203(2):105.e1-13. doi: 10.1016/j.ajog.2010.01.049. Epub 2010 Jul 1.

PMID:
20579960
11.

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis.

Güler-Yüksel M, Klarenbeek NB, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van der Kooij SM, Gerards AH, Ronday HK, Huizinga TW, Dijkmans BA, Allaart CF, Lems WF.

Arthritis Res Ther. 2010;12(3):R96. doi: 10.1186/ar3025. Epub 2010 May 20.

12.

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial.

Klarenbeek NB, van der Kooij SM, Huizinga TJ, Goekoop-Ruiterman YP, Hulsmans HM, van Krugten MV, Speyer I, de Vries-Bouwstra JK, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2010 Jul;69(7):1342-5. doi: 10.1136/ard.2009.124180. Epub 2010 May 14.

PMID:
20472597
13.

Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.

Kooloos WM, Wessels JA, van der Kooij SM, Allaart CF, Huizinga TW, Guchelaar HJ.

Ann Rheum Dis. 2009 Aug;68(8):1371. doi: 10.1136/ard.2008.096891. No abstract available.

PMID:
19605746
14.

Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Ewals JA, Han KH, Hazes JM, Kerstens PJ, Peeters AJ, van Zeben D, Breedveld FC, Huizinga TW, Dijkmans BA, Allaart CF.

Arthritis Rheum. 2009 Jan 15;61(1):4-12. doi: 10.1002/art.24367.

15.

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jul;68(7):1153-8. doi: 10.1136/ard.2008.093294. Epub 2008 Oct 17.

PMID:
18930988
16.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
17.

Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis.

Visser K, Verpoort KN, van Dongen H, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW, van der Helm-van Mil AH.

Ann Rheum Dis. 2008 Aug;67(8):1194-5. doi: 10.1136/ard.2008.088070. No abstract available.

PMID:
18621971
18.

Innovative treatment strategies for patients with rheumatoid arthritis.

van der Kooij SM, Allaart CF, Dijkmans BA, Breedveld FC.

Curr Opin Rheumatol. 2008 May;20(3):287-94. doi: 10.1097/BOR.0b013e3282fa13db. Review.

PMID:
18388520
19.

Comment on: The pharmacogenetics of methotrexate.

van der Kooij SM, Wessels JA, Huizinga TW, Guchelaar HJ.

Rheumatology (Oxford). 2008 Apr;47(4):557; author reply 5557-8. doi: 10.1093/rheumatology/kem386. Epub 2008 Jan 25. No abstract available.

PMID:
18222982
20.

A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis.

van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW.

Ann Rheum Dis. 2008 Jun;67(6):769-74. Epub 2007 Oct 26.

PMID:
17965124
21.

Probability of continued low disease activity in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Peeters AJ, van Krugten MV, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2008 Feb;67(2):266-9. Epub 2007 Oct 18.

PMID:
17947301
22.

A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.

Wessels JA, van der Kooij SM, le Cessie S, Kievit W, Barerra P, Allaart CF, Huizinga TW, Guchelaar HJ; Pharmacogenetics Collaborative Research Group.

Arthritis Rheum. 2007 Jun;56(6):1765-75.

23.

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, van Groenendael JH, Hazes JM, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2007 Oct;66(10):1356-62. Epub 2007 Feb 9.

Supplemental Content

Loading ...
Support Center